2 mg/0.5 mg (30 count)
Indication: Buprenorphine and naloxone sublingual tablet contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence.
Buprenorphine and naloxone sublingual tablet should be used as part of a treatment plan that includes counseling and psychosocial support.
Please see full Prescribing Information for more information.
Markings: White to off-white, round, biconvex uncoated tablet, debossed with a “↑” logo on one side and an “N2” on the other side.
Storage and Handling: Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F).